Pinnacle Associates’s Renalytix plc American Depositary Shares RNLX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-846,534
| Closed | -$330K | – | 904 |
|
2024
Q3 | $330K | Buy |
846,534
+31,109
| +4% | +$12.1K | 0.01% | 651 |
|
2024
Q2 | $188K | Buy |
815,425
+119,420
| +17% | +$27.6K | ﹤0.01% | 781 |
|
2024
Q1 | $599K | Sell |
696,005
-150,529
| -18% | -$129K | 0.01% | 552 |
|
2023
Q4 | $330K | Buy |
846,534
+60,572
| +8% | +$23.6K | 0.01% | 661 |
|
2023
Q3 | $1.26M | Sell |
785,962
-53,360
| -6% | -$85.4K | 0.02% | 422 |
|
2023
Q2 | $2.45M | Buy |
839,322
+32,525
| +4% | +$95K | 0.04% | 333 |
|
2023
Q1 | $1.95M | Buy |
806,797
+232,016
| +40% | +$561K | 0.04% | 308 |
|
2022
Q4 | $1.07M | Buy |
574,781
+121,655
| +27% | +$227K | 0.02% | 390 |
|
2022
Q3 | $580K | Buy |
453,126
+112,890
| +33% | +$144K | 0.01% | 476 |
|
2022
Q2 | $834K | Buy |
340,236
+35,392
| +12% | +$86.8K | 0.02% | 441 |
|
2022
Q1 | $2.11M | Buy |
304,844
+114,820
| +60% | +$795K | 0.04% | 337 |
|
2021
Q4 | $3.02M | Buy |
190,024
+1,235
| +0.7% | +$19.6K | 0.05% | 282 |
|
2021
Q3 | $3.79M | Buy |
188,789
+68,904
| +57% | +$1.38M | 0.07% | 250 |
|
2021
Q2 | $3.7M | Buy |
119,885
+21,904
| +22% | +$676K | 0.07% | 254 |
|
2021
Q1 | $2.51M | Buy |
97,981
+63,541
| +184% | +$1.63M | 0.05% | 295 |
|
2020
Q4 | $551K | Buy |
34,440
+9,800
| +40% | +$157K | 0.01% | 496 |
|
2020
Q3 | $300K | Buy |
+24,640
| New | +$300K | 0.01% | 560 |
|